A Virtual Recruitment Protocol Promotes Enrollment of Underrepresented Groups in a Diabetes Prevention Trial

Overview

Journal J Clin Transl Sci

Publisher Cambridge University Press

Date 2024 Feb 22

PMID 38384920

Authors

Natalie D Ritchie

Melanie T Turk

Jodi Summers Holtrop

Michael Josh Durfee

L Miriam Dickinson

Peter G Kaufmann

Affiliations

Soon will be listed here.

Abstract

Strategies are needed to ensure greater participation of underrepresented groups in diabetes research. We examined the impact of a remote study protocol on enrollment in diabetes research, specifically the Pre-NDPP clinical trial. Recruitment was conducted among 2807 diverse patients in a safety-net healthcare system. Results indicated three-fold greater odds of enrolling in remote versus in-person protocols (AOR 2.90; < 0.001 [95% CI 2.29-3.67]). Priority populations with significantly higher enrollment included Latinx and Black individuals, Spanish speakers, and individuals who had Medicaid or were uninsured. A remote study design may promote overall recruitment into clinical trials, while effectively supporting enrollment of underrepresented groups.

References

Kelsey M, Patrick-Lake B, Abdulai R, Broedl U, Brown A, Cohn E . Inclusion and diversity in clinical trials: Actionable steps to drive lasting change. Contemp Clin Trials. 2022; 116:106740. PMC: 9133187. DOI: 10.1016/j.cct.2022.106740. View

Cannon M, Ng B, Lloyd K, Reynolds J, Ely E . Delivering the National Diabetes Prevention Program: Assessment of Enrollment in In-Person and Virtual Organizations. J Diabetes Res. 2022; 2022:2942918. PMC: 8804550. DOI: 10.1155/2022/2942918. View

Ritchie N, Baucom K, Sauder K . Current Perspectives on the Impact of the National Diabetes Prevention Program: Building on Successes and Overcoming Challenges. Diabetes Metab Syndr Obes. 2020; 13:2949-2957. PMC: 7445538. DOI: 10.2147/DMSO.S218334. View

Moen M, Storr C, German D, Friedmann E, Johantgen M . A Review of Tools to Screen for Social Determinants of Health in the United States: A Practice Brief. Popul Health Manag. 2020; 23(6):422-429. PMC: 7864106. DOI: 10.1089/pop.2019.0158. View

Rothwell E, Brassil D, Barton-Baxter M, Brownley K, Dickert N, Ford D . Informed consent: Old and new challenges in the context of the COVID-19 pandemic. J Clin Transl Sci. 2021; 5(1):e105. PMC: 8193198. DOI: 10.1017/cts.2021.401. View

Ramsetty A, Adams C . Impact of the digital divide in the age of COVID-19. J Am Med Inform Assoc. 2020; 27(7):1147-1148. PMC: 7197532. DOI: 10.1093/jamia/ocaa078. View

Ritchie N, Gurfinkel D, Sajatovic M, Carter M, Glasgow R, Holtrop J . A Multi-Method Study of Patient Reach and Attendance in a Pragmatic Trial of Diabetes Shared Medical Appointments. Clin Diabetes. 2023; 41(4):526-538. PMC: 10577507. DOI: 10.2337/cd23-0015. View

Li G, Zhang J, Van Spall H, Douglas P, Wang Y, Sun X . Exploring ethnic representativeness in diabetes clinical trial enrolment from 2000 to 2020: a chronological survey. Diabetologia. 2022; 65(9):1461-1472. PMC: 9200441. DOI: 10.1007/s00125-022-05736-z. View

Nicholson L, Schwirian P, Groner J . Recruitment and retention strategies in clinical studies with low-income and minority populations: Progress from 2004-2014. Contemp Clin Trials. 2015; 45(Pt A):34-40. DOI: 10.1016/j.cct.2015.07.008. View

10.

Cunningham-Erves J, Joosten Y, Kusnoor S, Mayers S, Ichimura J, Dunkel L . A community-informed recruitment plan template to increase recruitment of racial and ethnic groups historically excluded and underrepresented in clinical research. Contemp Clin Trials. 2022; 125:107064. PMC: 9926351. DOI: 10.1016/j.cct.2022.107064. View

11.

Oh S, Galanter J, Thakur N, Pino-Yanes M, Barcelo N, White M . Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled. PLoS Med. 2015; 12(12):e1001918. PMC: 4679830. DOI: 10.1371/journal.pmed.1001918. View

12.

Ritchie N, Holtrop J, Gritz R, Sauder K, Durfee M, Dickinson L . Enhanced Enrollment in the National Diabetes Prevention Program to Increase Engagement and Weight Loss for the Underserved: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020; 9(6):e15499. PMC: 7296404. DOI: 10.2196/15499. View

13.

Ritchie N, Kaufmann P, Gritz R, Sauder K, Holtrop J . Presessions to the National Diabetes Prevention Program May be a Promising Strategy to Improve Attendance and Weight Loss Outcomes. Am J Health Promot. 2018; 33(2):289-292. DOI: 10.1177/0890117118786195. View

14.

Barron E, Bradley D, Safazadeh S, McGough B, Bakhai C, Young B . Effectiveness of digital and remote provision of the Healthier You: NHS Diabetes Prevention Programme during the COVID-19 pandemic. Diabet Med. 2022; 40(5):e15028. PMC: 9878108. DOI: 10.1111/dme.15028. View

15.

Small S, Lau E, McFarlane K, Archambault P, Longstaff H, Hohl C . Research recruitment and consent methods in a pandemic: a qualitative study of COVID-19 patients' perspectives. BMC Med Res Methodol. 2023; 23(1):113. PMC: 10173898. DOI: 10.1186/s12874-023-01933-5. View

16.

Welshons K, Johnson N, Gold A, Reicks M . Diabetes prevention program outcomes by in-person versus distance delivery mode among ethnically diverse, primarily lower-income adults. Digit Health. 2023; 9:20552076231173524. PMC: 10176546. DOI: 10.1177/20552076231173524. View

17.

Yeung A, Dirisanala S, Abraham A, Huang J, Brennan G, Urrutia M . Diabetes Research and Resource Sharing During the COVID-19 Pandemic: A Systematic Review and Experience from an Academic/Non-Profit Resource Website. J Diabetes Sci Technol. 2023; 17(5):1284-1294. PMC: 10345815. DOI: 10.1177/19322968231184448. View